Autologous Stem Cell Transplant Program at NYU Winthrop Hospital Cancer Center
At the Forefront of Cancer Care
Chemotherapy helps reduce malignant cancer cells. But the toxicity of chemotherapeutic agents can, in turn, diminish the production of – and damage -- healthy cells, including bone marrow stem cells. Stem cells are vital because they give rise to normal circulating blood cells. They are known as "grandfather" cells because they have yet to differentiate into the many types of cells that make up the human body.
State-of -the-Art Approach to Stem Cell Transplant Therapy
NYU Winthrop Hospital’s Autologous Stem Cell Transplant Program is offered through an inpatient or outpatient basis. Treatment involves the removal of stem cells prior to the administration of extremely high doses of chemotherapy. After treatment, the patient's stem cells are reinfused back into the body where they regenerate healthy new bone marrow.
With this program, patients with a wide variety of conditions have a better chance of recovery.
Our Dedicated Stem Cell Transplant Specialists
A multidisciplinary team approach is used to provide comprehensive care for adults and children undergoing transplantation. Our team of dedicated specialists includes medical hematologists/oncologists, transplant coordinators, nurse practitioners, oncology nurses, social workers, pharmacists, and nutritionists working together to develop an individualized treatment plan and help patients and their families through all phases of the autologous stem cell transplant process.
Conditions Treated at our Autologous Stem Cell Transplant Program
- Testicular Cancer
- Hodgkins Disease
- Non-Hodgkins Lymphoma
- Multiple Myeloma
Learn about our state-of-the-art Oncology/Hematology Infusion Center. With 13 infusion chairs situated in an open, comfortable setting, the Center provides treatments and prepares patients for stem cell transplant and its aftercare.